Insurance, Pharmaceutical Services
"Insurance, Pharmaceutical Services" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.
| Descriptor ID |
D007356
|
| MeSH Number(s) |
N03.219.521.576.343.575
|
| Concept/Terms |
Insurance, Pharmaceutical Services- Insurance, Pharmaceutical Services
- Pharmacy Services Insurance
- Pharmaceutic Services Insurance
- Pharmaceutical Services Insurance
- Insurance, Pharmaceutic Services
- Insurance, Pharmacy Services
Drug Benefit Plans- Drug Benefit Plans
- Drug Benefit Plan
- Plan, Drug Benefit
- Plans, Drug Benefit
|
Below are MeSH descriptors whose meaning is more general than "Insurance, Pharmaceutical Services".
Below are MeSH descriptors whose meaning is more specific than "Insurance, Pharmaceutical Services".
This graph shows the total number of publications written about "Insurance, Pharmaceutical Services" by people in this website by year, and whether "Insurance, Pharmaceutical Services" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insurance, Pharmaceutical Services" by people in Profiles.
-
Coverage for Biosimilars vs Reference Products Among US Commercial Health Plans. JAMA. 2020 05 19; 323(19):1972-1973.
-
Strategies that delay or prevent the timely availability of affordable generic drugs in the United States. Blood. 2016 Mar 17; 127(11):1398-402.
-
Evaluating Pharmacist-Written Recommendations to Providers in a Medicare Advantage Plan: Factors Associated with Provider Acceptance. J Manag Care Spec Pharm. 2016 Jan; 22(1):49-55.
-
Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011. J Clin Oncol. 2015 Jul 01; 33(19):2190-6.
-
An evaluation of three statistical estimation methods for assessing health policy effects on prescription drug claims. Res Social Adm Pharm. 2016 Jan-Feb; 12(1):29-40.
-
Impact of incorporating pharmacy claims data into electronic medication reconciliation. Am J Health Syst Pharm. 2015 Feb 01; 72(3):212-7.
-
Perception of generic prescription drugs and utilization of generic drug discount programs. Ethn Dis. 2012; 22(4):479-85.
-
Economic effect of an expansion of pharmacy benefits on total health care expenditures by a state Medicaid program. J Am Pharm Assoc (2003). 2009 Nov-Dec; 49(6):744-50.
-
The association of Medicare drug coverage with use of evidence-based medications in the Veterans Health Administration. Ann Pharmacother. 2009 Oct; 43(10):1565-75.
-
Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7.